These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Illicit bath salts: not for bathing. Kyle PB, Iverson RB, Gajagowni RG, Spencer L. J Miss State Med Assoc; 2011 Dec; 52(12):375-7. PubMed ID: 22329114 [Abstract] [Full Text] [Related]
6. Implications of psychoactive 'bath salts' use during pregnancy. Gray BA, Holland C. Nurs Womens Health; 2014 Dec; 18(3):220-30. PubMed ID: 24939199 [Abstract] [Full Text] [Related]
7. Bath salts and synthetic cathinones: an emerging designer drug phenomenon. German CL, Fleckenstein AE, Hanson GR. Life Sci; 2014 Feb 27; 97(1):2-8. PubMed ID: 23911668 [Abstract] [Full Text] [Related]
8. Changes in neuronal activity in rat primary cortical cultures induced by illicit drugs and new psychoactive substances (NPS) following prolonged exposure and washout to mimic human exposure scenarios. Zwartsen A, Hondebrink L, Westerink RH. Neurotoxicology; 2019 Sep 27; 74():28-39. PubMed ID: 31078573 [Abstract] [Full Text] [Related]
9. Toxicology and management of novel psychoactive drugs. Kersten BP, McLaughlin ME. J Pharm Pract; 2015 Feb 27; 28(1):50-65. PubMed ID: 25261428 [Abstract] [Full Text] [Related]
10. New Psychoactive Substances: A Matter of Time. Pantano F, Graziano S, Pacifici R, Busardò FP, Pichini S. Curr Neuropharmacol; 2019 Feb 27; 17(9):818-822. PubMed ID: 31577198 [Abstract] [Full Text] [Related]
12. The toxicology of bath salts: a review of synthetic cathinones. Prosser JM, Nelson LS. J Med Toxicol; 2012 Mar 11; 8(1):33-42. PubMed ID: 22108839 [Abstract] [Full Text] [Related]
13. The value of toxicological and forensic analyses in the global challenge to health risks caused by new psychoactive substances. Zaami S, Busardò FP, Pichini S, Pacifici R, Marinelli E. Eur Rev Med Pharmacol Sci; 2019 Jul 11; 23(14):6008-6010. PubMed ID: 31364102 [No Abstract] [Full Text] [Related]
14. Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as "bath salts" or "plant food". Coppola M, Mondola R. Toxicol Lett; 2012 Jun 01; 211(2):144-9. PubMed ID: 22459606 [Abstract] [Full Text] [Related]
15. Synthetic legal intoxicating drugs: the emerging 'incense' and 'bath salt' phenomenon. Jerry J, Collins G, Streem D. Cleve Clin J Med; 2012 Apr 01; 79(4):258-64. PubMed ID: 22473725 [Abstract] [Full Text] [Related]
16. Unexpected identification and characterization of a cathinone precursor in the new psychoactive substance market: 3',4'-methylenedioxy-2,2-dibromobutyrophenone. Armenta S, Gil C, Ventura M, Esteve-Turrillas FA. Forensic Sci Int; 2020 Jan 01; 306():110043. PubMed ID: 31743834 [Abstract] [Full Text] [Related]
17. Clinical and pharmacological aspects of bath salt use: a review of the literature and case reports. Miotto K, Striebel J, Cho AK, Wang C. Drug Alcohol Depend; 2013 Sep 01; 132(1-2):1-12. PubMed ID: 23916320 [Abstract] [Full Text] [Related]
18. Designer drugs: a medicinal chemistry perspective (II). Carroll FI, Lewin AH, Mascarella SW, Seltzman HH, Reddy PA. Ann N Y Acad Sci; 2021 Apr 01; 1489(1):48-77. PubMed ID: 32396701 [Abstract] [Full Text] [Related]
19. Khat and synthetic cathinones: a review. Valente MJ, Guedes de Pinho P, de Lourdes Bastos M, Carvalho F, Carvalho M. Arch Toxicol; 2014 Jan 01; 88(1):15-45. PubMed ID: 24317389 [Abstract] [Full Text] [Related]
20. DARK Classics in Chemical Neuroscience: α-Pyrrolidinovalerophenone ("Flakka"). Kolesnikova TO, Khatsko SL, Demin KA, Shevyrin VA, Kalueff AV. ACS Chem Neurosci; 2019 Jan 16; 10(1):168-174. PubMed ID: 30384587 [Abstract] [Full Text] [Related] Page: [Next] [New Search]